Shingai Machingaidze

Oct 14, 2024 | bmj.com | Gavin Yamey |Shingai Machingaidze |Hymowitz professor

Gavin Yamey, Hymowitz professor of global health and professor of public policy1, Shingai Machingaidze, global health consultant21Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University2South AfricaThis year has seen a double dose of optimism in the field of HIV prevention.

Sep 6, 2024 | time.com | Gavin Yamey |Marco Schäferhoff |Shingai Machingaidze

Ideas By Gavin Yamey, Marco Schäferhoff and Shingai Machingaidze September 6, 2024 4:08 PM EDT Yamey is a physician and professor of global health and public policy at Duke University, where he directs the Center for Policy Impact in Global Health Schäferhoff is the co-founder and managing director of Open Consultants, a global health consultancy based in Berlin Machingaidze is an epidemiologist and global health consultant with significant experience developing and leading public health and...

Jul 22, 2024 | brookings.edu | Gavin Yamey |Shingai Machingaidze |Osondu Ogbuoji |Marco Schäferhoff

Investments in global health research and development (R&D) have led to the launches of many life-saving health technologies. Twenty years ago, for example, we had no malaria vaccine. Today, two effective malaria vaccines are being rolled out across Africa. And the future looks bright: The pipeline of candidate products for most global health conditions is more robust than ever (though some neglected diseases, such as leprosy, scabies, and trachoma, still have too few candidate products).